Bengt Ingemar Samuelsson
Corporate Officer/Principal chez Royal Swedish Academy of Sciences
Profil
Bengt Ingemar Samuelsson is the founder of NovaSAID AB and LTB4 Sweden AB (founded in 2004).
He held the title of Chairman at The Nobel Foundation from 1993 to 2005.
Dr. Samuelsson's current jobs include Senior Advisor at HealthCap AB, Member at the Royal Swedish Academy of Sciences, Professor at Karolinska Institutet, and Member at the Royal Society, French Academy of Sciences, and American Academy of Sciences.
Dr. Samuelsson's former jobs include Director at The Liposome Co., Inc., Pharmacia & Upjohn, Inc., Nicox SA, BioStratum, Inc., Orexo AB, Biolipox AB, Apoxis SA, Life Science Analytics, Inc., and Member-Advisory Board at Odlander, Fredrikson & Co. AB.
Dr. Samuelsson received his undergraduate degree from Karolinska Institutet in 1960.
Dr. Samuelsson is also the founder of RSPR Pharma AB.
Postes actifs de Bengt Ingemar Samuelsson
Sociétés | Poste | Début |
---|---|---|
Royal Swedish Academy of Sciences
Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Corporate Officer/Principal | 14/08/2009 |
American Academy of Sciences | Corporate Officer/Principal | 14/08/2009 |
French Academy of Sciences
French Academy of Sciences Other Consumer ServicesConsumer Services French Academy of Sciences engages in protection of spirit of French scientific research. The firm offers science teaching, transmitting knowledge, international collaboration and advice. The company was founded by Jean-Baptiste Colbert in 1666 and is headquartered in Paris, France. | Corporate Officer/Principal | 14/08/2009 |
The Royal Society | Corporate Officer/Principal | 14/08/2009 |
Karolinska Institutet | Corporate Officer/Principal | 12/05/2010 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Consultant / Advisor | - |
Anciens postes connus de Bengt Ingemar Samuelsson
Sociétés | Poste | Fin |
---|---|---|
NICOX SA | Director/Board Member | 21/06/2013 |
OREXO AB | Director/Board Member | 11/04/2012 |
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Director/Board Member | 24/02/2009 |
░░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Bengt Ingemar Samuelsson
Karolinska Institutet | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
NICOX SA | Health Technology |
OREXO AB | Health Technology |
Entreprise privées | 16 |
---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
Pharmacia & Upjohn, Inc. | Health Technology |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Finance |
Odlander, Fredrikson & Co. AB
Odlander, Fredrikson & Co. AB Financial ConglomeratesFinance Odlander Fredrikson & Co. AB provides financial support services. The company was founded in 1996 and is headquartered in Stockholm, Sweden. | Finance |
Royal Swedish Academy of Sciences
Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Commercial Services |
BioStratum, Inc.
BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Health Technology |
The Royal Society | Miscellaneous |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Health Technology |
Apoxis SA
Apoxis SA Pharmaceuticals: MajorHealth Technology Apoxis SA develops therapeutics for the treatment of cancer and immunological diseases based on the mechanisms underlying apoptosis or cell death. The company particularly focuses on diseases with unmet medical needs and high commercial potential. It's lead product, APO866, is a novel small molecule therapeutic for the treatment of a range of cancers. The product is also being evaluated in a range of cancers in combination with commonly used chemo and radiotherapies in preclinical studies. It's oncology portfolio also includes APO010, a protein therapeutic that was developed using the company’s proprietary multimerization technology. The company is headquartered in Lausanne, Switzerland. | Health Technology |
The Nobel Foundation | Miscellaneous |
Life Science Analytics, Inc.
Life Science Analytics, Inc. Investment ManagersFinance Life Science Analytics, Inc. is a research firm headquartered in Scranton, Pennsylvania. They are a subsidiary of Datamonitor Ltd. and their ultimate parent is Informa Plc (LON: INF) in Great Britain. The firm provides comprehensive pipeline and financial information on more than 13,000 biomedical companies worldwide. Their data and research products serve executives in the pharmaceutical, biotech, and financial industries. | Finance |
French Academy of Sciences
French Academy of Sciences Other Consumer ServicesConsumer Services French Academy of Sciences engages in protection of spirit of French scientific research. The firm offers science teaching, transmitting knowledge, international collaboration and advice. The company was founded by Jean-Baptiste Colbert in 1666 and is headquartered in Paris, France. | Consumer Services |
American Academy of Sciences | |
RSPR Pharma AB
RSPR Pharma AB Pharmaceuticals: MajorHealth Technology RSPR Pharma AB develops therapeutics for inflammatory vascular diseases. The firm's products are used to treat diseases such as atherosclerosis and abdominal aortic aneurysm. The company was founded by Carl-Johan Dalsgaard in 2006 and is headquartered in Stockholm, Sweden. | Health Technology |
LTB4 Sweden AB
LTB4 Sweden AB BiotechnologyHealth Technology LTB4 Sweden AB engages in research and product development related to antimicrobial and anti-inflammatory substances through its subsidiaries. The company was founded by Bengt Ingemar Samuelsson on February 26, 2004 and is headquartered in Stockholm, Sweden. | Health Technology |
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Health Technology |